Back
Recursion Pharmaceuticals Vs. Sable Offshore Industry Stock Comparison
Buy
57
RXRX
Recursion Pharmaceuticals
Last Price:
$5.49
Seasonality Move:
7.58%
Buy
61
SOC
Sable Offshore
Last Price:
$24.49
Seasonality Move:
4.51%
Buy
57
Recursion Pharmaceuticals (RXRX)
is a Buy
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
-
The current Recursion Pharmaceuticals [RXRX] share price is $5.49. The Score for RXRX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RXRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Sable Offshore (SOC)
is a Buy
Is Sable Offshore a Buy, Sell or Hold?
-
The current Sable Offshore [SOC] share price is $24.50. The Score for SOC is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
SOC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $5.49Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SOC Stock Price Chart
What is Sable Offshore's stock price today?
-
The Sable Offshore share price today is $24.50Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SOC is experiencing slight buying pressure.
RXRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 61.38 | Buy |
| Chaikin Money Flow: | 55882068 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.11 - 4.87) | Buy |
| Bollinger Bands (100): | (4.57 - 7.67) | Sell |
SOC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.31 | Buy |
| Relative Strength Index (14 RSI): | 45.16 | Sell |
| Chaikin Money Flow: | 882052 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.29 - 31.15) | Sell |
| Bollinger Bands (100): | (20.8 - 28.76) | Sell |
RXRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.59 | Buy |
| 20-day SMA: | 4.46 | Buy |
| 50-day SMA: | 4.89 | Buy |
| 200-day SMA: | 6.47 | Sell |
| 8-day EMA: | 4.71 | Buy |
| 20-day EMA: | 4.63 | Buy |
| 50-day EMA: | 5.06 | Buy |
| 200-day EMA: | 6.42 | Sell |
SOC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.03 | Sell |
| 20-day SMA: | 28.33 | Sell |
| 50-day SMA: | 23.63 | Buy |
| 200-day SMA: | 23.25 | Buy |
| 8-day EMA: | 25.86 | Sell |
| 20-day EMA: | 26.5 | Sell |
| 50-day EMA: | 25.21 | Sell |
| 200-day EMA: | 22.49 | Buy |
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.25 per share.
Sable Offshore Earnings Growth & SOC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.21 per share, an increase next quarter of $0.30 per share, an increase this year of $5.72 per share, and an increase next year of $4.60 per share.
Recursion Pharmaceuticals Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sable Offshore Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||